uniQure NV (QURE)
4.93
+0.25
(+5.34%)
USD |
NASDAQ |
May 31, 16:00
4.94
+0.01
(+0.20%)
After-Hours: 20:00
uniQure Cash from Financing (Quarterly): 0.00 for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.046M |
| September 30, 2023 | -7.593M |
| June 30, 2023 | 370.14M |
| March 31, 2023 | 0.131M |
| December 31, 2022 | 0.601M |
| September 30, 2022 | 0.301M |
| June 30, 2022 | 0.058M |
| March 31, 2022 | 0.485M |
| December 31, 2021 | 29.89M |
| September 30, 2021 | -0.164M |
| June 30, 2021 | 2.51M |
| March 31, 2021 | 62.62M |
| December 31, 2020 | 3.756M |
| September 30, 2020 | 0.139M |
| June 30, 2020 | 2.539M |
| March 31, 2020 | 1.01M |
| December 31, 2019 | 1.31M |
| September 30, 2019 | 244.29M |
| June 30, 2019 | 0.543M |
| March 31, 2019 | 2.678M |
| December 31, 2018 | 14.84M |
| September 30, 2018 | 1.639M |
| Date | Value |
|---|---|
| June 30, 2018 | 139.92M |
| March 31, 2018 | 1.562M |
| December 31, 2017 | 89.04M |
| September 30, 2017 | 0.097M |
| June 30, 2017 | 0.498M |
| March 31, 2017 | 0.441M |
| December 31, 2016 | 0.376M |
| September 30, 2016 | -0.028M |
| June 30, 2016 | 1.325M |
| March 31, 2016 | 0.772M |
| December 31, 2015 | 6.345M |
| September 30, 2015 | 40.75M |
| June 30, 2015 | 113.49M |
| March 31, 2015 | 0.1148M |
| December 31, 2014 | 6.602M |
| September 30, 2014 | -6.490M |
| June 30, 2014 | 9.128M |
| March 31, 2014 | 85.15M |
| December 31, 2013 | 1.030M |
| September 30, 2013 | 19.80M |
| June 30, 2013 | 10.03M |
| March 31, 2013 | 15.60M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-7.593M
Minimum
Sep 2023
370.14M
Maximum
Jun 2023
35.63M
Average
0.572M
Median
Cash from Financing (Quarterly) Benchmarks
| ProQR Therapeutics NV | -0.4551M |
| Merus NV | 30.16M |
| argenx SE | -- |
| Pharming Group | -2.471M |
| Pharvaris NV | 0.8636M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -60.58M |
| Cash from Investing (Quarterly) | 63.98M |
| Free Cash Flow | -135.36M |
| Free Cash Flow Per Share (Quarterly) | -1.300 |
| Free Cash Flow to Equity (Quarterly) | -63.29M |
| Free Cash Flow to Firm (Quarterly) | -53.23M |
| Free Cash Flow Yield | -57.31% |